Soft Tissue Repair Sports Medicine

U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market (Rotator Cuff Repair, Vaginal Prolapse, Lateral Epicondylitis, Achilles Tendinosis Repair, Gluteal Tendon/Trochanteric Bursitis Repair and Anterior Cruciate Ligament (ACL) Reconstruction): Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • Rep Id : TMRGL1768
  • Published On : Jan 2015
  • No. of Pages : 101
  • Category : Healthcare

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
              1.3.1.1 Secondary Research
              1.3.1.2 Primary Research
      1.3.2 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Orthopedic Soft Tissue Surgical Procedures Market (2013 & 2020)
2.2 Orthopedic Soft Tissue Surgical Procedures Market, by Geography, 2013 (USD Million)
 
Chapter 3 Orthopedic Soft Tissue Surgical Procedures Market Overview
3.1 Overview
      3.1.1 Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Geography, 2012 – 2020 (USD Million)
3.2 Market Dynamics
      3.2.1 Market Drivers
              3.2.1.1 Aging population coupled with growing participation in sports activities boost market growth
              3.2.1.2 Increasing number of sports medicine associations would promote market growth
              3.2.1.3 Growing trend of minimally invasive procedures promotes market expansion
              3.2.1.4 Advancements in orthopedic surgical products drive demand for soft tissue surgeries, thereby boosting market growth
      3.2.2 Market Restraints
              3.2.2.1 Asymptomatic nature of orthopedic injuries and availability of non-operative treatments restrains growth
              3.2.2.2 High cost of surgeries and rising trend of medical tourism hampers market growth
      3.2.3 Opportunities
              3.2.3.1 Strong research and development activities to develop novel orthopedic surgical products provides good platform to record high growth
3.3 Porter’s Five Force Analysis: Orthopedic Soft Tissue Surgical Procedures Market, by Products
      3.3.1 Bargaining power of suppliers
      3.3.2 Bargaining power of buyers
      3.3.3 Threat of new entrants
      3.3.4 Threat of substitutes
      3.3.5 Competitive rivalry
3.4 Event Impact Analysis
3.5 Regulatory Scenario
      3.5.1 U.S.
              3.5.1.1 Major Steps: U.S. FDA Regulatory Approval Pathway
      3.5.2 Europe
              3.5.2.1 Major Steps: CE Marking Regulatory Approval Pathway
      3.5.3 Japan
3.6 Market Attractiveness Analysis: Orthopedic Soft Tissue Surgical Procedures Market, by Geography
3.7 Competitive Landscape
      3.7.1 U.S., Europe, and Japan Orthopedic Soft Tissue Surgical Procedures Market Share Analysis, by Key Players, 2013 (%)
 
Chapter 4 U.S. Orthopedic Soft Tissue Surgical Procedures Market, by Indications
4.1 Overview
      4.1.1 U.S. Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
4.2 Rotator Cuff Repair
      4.2.1 U.S. Rotator Cuff Repair Market Revenue, 2012 – 2020 (USD Million)
4.3 Vaginal Prolapse
      4.3.1 U.S. Vaginal Prolapse Market Revenue, 2012 – 2020 (USD Million)
4.4 Lateral Epicondylitis
      4.4.1 U.S. Lateral Epicondylitis Market Revenue, 2012 – 2020 (USD Million)
4.5 Achilles Tendinosis Repair
      4.5.1 U.S. Achilles Tendinosis Repair Market Revenue, 2012 – 2020 (USD Million)
4.6 Gluteal Tendon/Trochanteric Bursitis Repair
      4.6.1 U.S. Gluteal Tendon Repair Market Revenue, 2012 – 2020 (USD Million)
4.7 Anterior Cruciate Ligament (ACL) Reconstruction
      4.7.1 U.S. ACL Reconstruction Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 5 Europe Orthopedic Soft Tissue Surgical Procedures Market, by Indications
5.1 Overview
      5.1.1 Europe Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
5.2 Rotator Cuff Repair
      5.2.1 Europe Rotator Cuff Repair Market Revenue, 2012 – 2020 (USD Million)
5.3 Vaginal Prolapse
      5.3.1 Europe Vaginal Prolapse Market Revenue, 2012 – 2020 (USD Million)
5.4 Lateral Epicondylitis
      5.4.1 Europe Lateral Epicondylitis Market Revenue, 2012 – 2020 (USD Million)
5.5 Achilles Tendinosis Repair
      5.5.1 Europe Achilles Tendinosis Repair Market Revenue, 2012 – 2020 (USD Million)
5.6 Gluteal Tendon / Trochanteric Bursitis Repair
      5.6.1 Europe Gluteal Tendon Repair Market Revenue, 2012 – 2020 (USD Million)
5.7 Anterior Cruciate Ligament (ACL) Reconstruction
      5.7.1 Europe Anterior Cruciate Ligament Reconstruction Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 6 Japan Orthopedic Soft Tissue Surgical Procedures Market, by Indications
6.1 Overview
      6.1.1 Japan Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
6.2 Rotator Cuff Repair
      6.2.1 Japan Rotator Cuff Repair Market Revenue , 2012 – 2020 (USD Million)
6.3 Vaginal Prolapse
      6.3.1 Japan Vaginal Prolapse Market Revenue , 2012 – 2020 (USD Million)
6.4 Lateral Epicondylitis
      6.4.1 Japan Lateral Epicondylitis Market Revenue , 2012 – 2020 (USD Million)
6.5 Achilles Tendinosis Repair
      6.5.1 Japan Achilles Tendinosis Repair Market Revenue , 2012 – 2020 (USD Million)
6.6 Gluteal Tendon / Trochanteric Bursitis Repair
      6.6.1 Japan Gluteal Tendon Market Revenue , 2012 – 2020 (USD Million)
6.7 Anterior Cruciate Ligament (ACL) Reconstruction
      6.7.1 Japan ACL Reconstruction Market Revenue , 2012 – 2020 (USD Million)
 
Chapter 7 Recommendations
7.1 Market Strategy for Success
      7.1.1 Strategic alliance, mergers and acquisitions offer a strong platform for companies to expand their geographic presence
      7.1.2 Organize marketing campaigns that highlight the cost benefits and clinical advantages of the products and orthopedic surgeries
      7.1.3 Long-term contracts with health care service providers and orthopedic surgeons
 
Chapter 8 Company Profiles
8.1 Arthrex, Inc.
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 ArthroCare Corporation
      8.2.1 Company Profile
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Biomet, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Development
8.4 CONMED Corporation
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 DePuy Synthes, Inc.
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Smith & Nephew plc
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 Stryker Corporation
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments

List of Tables
 
TABLE 1 Market Snapshot: Orthopedic Soft Tissue Surgical Procedures Market (2013 & 2020)
TABLE 2 Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Geography, 2012 – 2020 (USD Million)
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 U.S. Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
TABLE 6 Europe Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)
TABLE 7 Japan Orthopedic Soft Tissue Surgical Procedures Market Revenue, by Indications, 2012 – 2020 (USD Million)

List of Figures
 
FIG. 1 Orthopedic Soft Tissue Surgical Procedures: Market Segmentation
FIG. 2 Orthopedic Soft Tissue Surgical Procedures Market, by Geography, 2013 (USD Million)
FIG. 3 Porter’s Five Forces Analysis: Orthopedic Soft Tissue Surgical Procedures Market, by Products
FIG. 4 Major Steps: U.S. FDA Regulatory Approval Pathway
FIG. 5 Major Steps: CE Marking Regulatory Approval Pathway
FIG. 6 Market Attractiveness Analysis: Orthopedic Soft Tissue Surgical Procedures Market, by Geography
FIG. 7 U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures: Market Share, by Key Players, 2013 (%)
FIG. 8 U.S. Rotator Cuff Repair Market Revenue, 2012 - 2020 (USD Million)
FIG. 9 U.S. Vaginal Prolapse Market Revenue, 2012 - 2020 (USD Million)
FIG. 10 U.S. Lateral Epicondylitis Market Revenue, 2012 - 2020 (USD Million)
FIG. 11 U.S. Achilles Tendinosis Repair Market Revenue, 2012 - 2020 (USD Million)
FIG. 12 U.S. Gluteal Tendon Repair Market Revenue, 2012 - 2020 (USD Million)
FIG. 13 U.S. ACL Reconstruction Market Revenue, 2012 - 2020 (USD Million)
FIG. 14 Europe Rotator Cuff Repair Market Revenue, 2012 - 2020 (USD Million)
FIG. 15 Europe Vaginal Prolapse Market Revenue, 2012 - 2020 (USD Million)
FIG. 16 Europe Lateral Epicondylitis Market Revenue, 2012 - 2020 (USD Million)
FIG. 17 Europe Achilles Tendinosis Repair Market Revenue, 2012 - 2020 (USD Million)
FIG. 18 Europe Gluteal Tendon Repair Market Revenue, 2012 - 2020 (USD Million)
FIG. 19 Europe Anterior Cruciate Ligament Reconstruction Market Revenue, 2012 - 2020 (USD Million)
FIG. 20 Japan Rotator Cuff Repair Market Revenue, 2012 - 2020 (USD Million)
FIG. 21 Japan Vaginal Prolapse Market Revenue, 2012 - 2020 (USD Million)
FIG. 22 Japan Lateral Epicondylitis Market Revenue, 2012 - 2020 (USD Million)
FIG. 23 Japan Achilles Tendinosis Repair Market Revenue, 2012 - 2020 (USD Million)
FIG. 24 Japan Gluteal Tendon Market Revenue, 2012 - 2020 (USD Million)
FIG. 25 Japan ACL Reconstruction Market Revenue, 2012 - 2020 (USD Million)
FIG. 26 ArthroCare Corporation, Annual Revenue: 2011 – 2013 (USD Million)
FIG. 27 CONMED Corporation: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 28 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (USD Million)
FIG. 29 Smith & Nephew plc: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 30 Stryker Corporation, Annual Revenue, 2011 – 2013 (USD Million)